Media
From Trials to Hope: A New Approach to Treating Pancreatic Cancer
September 27, 2025
Shaun Bagai, CEO of RenovoRx, joined us to discuss an innovative approach delivering chemo directly to pancreatic tumors. By targeting…
RenovoRx Panther Study Progresses with First Clinical Procedure
September 26, 2025
RenovoRx has initiated its PanTheR post-marketing registry with the first registry-eligible patient procedure completed at the University of Vermont Cancer…
How Skipping The CRO Helped RenovoRx Get Closer To Patients
September 24, 2025
In this Q&A, RenovoRx Chief Clinical Officer Leesa Gentry explains why they decided to forgo a CRO partner, discusses their…
PharmaShots Webinar: Mastering a Patient-Centric Approach for Treatment in Biopharma
August 29, 2025
Shaun Bagai, CEO of RenovoRx, shares insights on the company’s recent patents, ongoing clinical trials, and its upcoming presentation at…
RenovoRx Updates Pivotal TIGeR-PaC Trial of Pancreatic Cancer Treatment
August 20, 2025
RenovoRx, Inc. announced an update of its ongoing pivotal phase 3 TIGeR-PaC trial, which is evaluating the company’s first investigational…
RenovoRx Launches Post-Marketing Study to Advance Real-World Use of RenovoCath Device
July 28, 2025
RenovoRx's PanTheR study evaluates the RenovoCath device's long-term safety and effectiveness in treating solid tumors through real-world data collection.…
Interventional Approaches for Locally Advanced Pancreatic Cancer
November 20, 2024
Ripal Gandhi, MD, FSVM, Miami Cardiac and Vascular Institute, Florida, discusses the new and upcoming approaches for treating locally advanced…
Trans-Arterial Micro-Perfusion For Improved Drug Delivery
June 19, 2024
The majority of benign and malignant tumors thrive in a highly vascularized microenvironment. Tumors depend on existing or newly formed…
Intra-Arterial Approach to Locally Advanced Pancreatic Cancer
August 30, 2023
The use of catheter-based localised delivery of drugs for treatment of cancer patients has proven to be effective and provides…